Effect of High-Intensity Interval Training Versus Home-Based Rehabilitation Program On Patients Underwent Coronary Artery Bypass Graft Surgery
18 augustus 2026 bijgewerkt door: Mohammed Obaid Almuzaini, Kafrelsheikh University
Effect of High-Intensity Interval Training Versus Home-Based Rehabilitation Program on Peak Metabolic Equivalents On Patients Underwent Coronary Artery Bypass Graft Surgery
- To assess the effect of high-intensity interval training on peak metabolic equivalents in patients with coronary heart disease after the coronary artery bypass grafting surgery.
- To assess the effect of a home-based cardiac rehabilitation program on peak metabolic equivalents in patients with coronary heart disease after coronary artery bypass grafting surgery.
- To compare functional outcomes between the different treatment approaches.
Studie Overzicht
Toestand
Werving
Gedetailleerde beschrijving
Cardiovascular disease (CVD), a leading cause of death in the U.S., is primarily driven by coronary artery disease (CAD), which accounts for 85% of related fatalities.
The Coronary Artery Bypass Grafting (CABG) procedure, used to treat blocked arteries, can lead to complications like reduced cardiopulmonary function and decreased physical activity post-surgery.
To combat these issues, cardiac rehabilitation (CR) is recommended, incorporating exercise, dietary changes, and stress reduction.
Research indicates that CR, particularly high-intensity interval training (HIIT), is safe for coronary artery disease patients and effectively enhances cardiopulmonary fitness.
Maintaining exercise capacity is critical as it significantly correlates with improved survival rates in Cardiovascular disease patients.
Despite evidence supporting cardiac rehabilitation's benefits, participation rates remain low, highlighting a need for sustained exercise habits post-rehabilitation.
Home-based CR has shown effectiveness comparable to outpatient programs, although long-term benefits remain uncertain due to insufficient follow-up studies.
Studietype
Ingrijpend
Inschrijving (Geschat)
84
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: Mohammed O Almuzaini, PT
- Telefoonnummer: +966540044491
- E-mail: Pt.mohammedobaid@gmail.com
Studie Locaties
-
-
-
Madinah, Saoedi-Arabië
- Werving
- Medina Cardiac Center
-
Contact:
- Mohammed Obaid Almuzaini, physical therapist
- Telefoonnummer: +966540044491
- E-mail: Pt.mohammedobaid@gmail.com
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Nee
Beschrijving
Inclusion Criteria:
- Participants will be eligible if they are clinically stable as defined by the American College of Cardiology/American Heart Association.
- Only Participants will be stratified as low to moderate risk as identified by the American College of Sport Medicine/
- Mean age ± standard deviation, 55 ± 3 years.
- All patients underwent coronary artery bypass graft surgery, rested at home for at least one month, and then returned to the center for a cardiac rehabilitation program
Exclusion Criteria:
- Patients will be excluded from this study if they had an ejection fraction of less than 40% at rest (high risk as defined by American Association of Cardiovascular and Pulmonary Rehabilitation Stratification).
- Mental health disorders (such an anxiety or depression).
- Any vision or hearing defects or any neurological, respiratory, or musculoskeletal conditions that have an impact on ambulation.
- Irreversible heart failure.
- Myocardial Infarction (MI) over the past month.
- Persistent ventricular arrhythmias or unstable angina.
- Any exercise restrictions.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: High Intensity Interval Training program
Twenty-eight patients will receive a high-intensity interval training program for four weeks
|
High-Intensity Interval Training (HIIT) includes a 5-minute warm-up, followed by a 3-minute training session at 60% to 70% of heart rate reserve and four 4-minute high-intensity intervals at 80% to 90% of heart rate reserve.
Each interval is followed by a 3-minute active recovery at 60% to 70% of heart rate reserve, concluding with a 4-minute cool-down.
Subjects without balance or leg issues performed treadmill exercises, while those with such complaints used a leg ergo-cycle.
|
|
Experimenteel: home-based cardiac rehabilitation intervention
Twenty-eight patients will receive a home-based cardiac rehabilitation intervention for four weeks
|
The home-based cardiac rehabilitation program utilizes Physio-tools software for exercise management.
Participants will receive a data sheet for exercise logging, a color-coded program, and a Polar watch.
Weekly phone support will provide encouragement and answer questions.
The program involves moderate-intensity exercises, 3 times a week, including circuit training for 45 minutes, with structured warm-up, aerobic, and cool-down phases.
|
|
Actieve vergelijker: no intervention
all participants will be given an instruction booklet that contains instructions and precautions about surgery, wound care and encouragement to be active.
|
The control group had no intervention program.
Based on current standard practice, all participants will be given an instruction booklet that contains instructions and precautions about surgery, wound care and encouragement to be active.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
assessment of Exercise capacity
Tijdsspanne: At baseline and after 4 weeks
|
Exercise capacity will be evaluated through a symptom-limited graded treadmill exercise test following the Bruce protocol, starting at 1.7 mph and a 10% incline.
The intensity will increase every 3 minutes until the participant reaches exhaustion or meets clinical termination criteria.
Capacity will be measured in metabolic equivalents (METs), with peak metabolic equivalents calculated based on the highest workload achieved.
Estimated oxygen consumption will be expressed in mL·kg-¹·min-¹ and converted to METs.
The main outcome will be the change in peak metabolic equivalents from baseline to post-intervention assessment.
|
At baseline and after 4 weeks
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
1 juli 2026
Primaire voltooiing (Geschat)
1 december 2026
Studie voltooiing (Geschat)
1 februari 2027
Studieregistratiedata
Eerst ingediend
28 juli 2026
Eerst ingediend dat voldeed aan de QC-criteria
18 augustus 2026
Eerst geplaatst (Werkelijk)
20 augustus 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
20 augustus 2026
Laatste update ingediend die voldeed aan QC-criteria
18 augustus 2026
Laatst geverifieerd
1 augustus 2026
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Mohamed_Msc
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .